Measured by its binding ability in a functional ELISA. When Recombinant Human LILRB5/CD85c/LIR-8 is immobilized at 0.5 µg/mL (100 µL/well), Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with an ED50 of 0.03-0.24 μg/mL.
CD85 antigen-like family member C | CD85c antigen | CD85c | Leukocyte immunoglobulin-like receptor 8 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains) | LILRB5 | LIR8 | LIR-8 | LIR-8leukocyte immunoglobulin-like receptor sub
规格或纯度
无动物源,无载体,生物活性,ActiBioPure™,His标签,≥95%(SDS-PAGE)
生化机理
可作为 I 类 MHC 抗原的受体。
生物活性
Measured by its binding ability in a functional ELISA. When Recombinant Human LILRB5/CD85c/LIR-8 is immobilized at 0.5 µg/mL (100 µL/well), Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with an ED50 of 0.03-0.24 μg/mL.
Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH 7.4
复溶
Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
储存条件
-20°C储存,避免反复冻融
运输条件
超低温运输
稳定性与储存
在 -20~-80℃ 下可保存 1 年以上。复溶后建议分装。避免冷冻/解冻循环。
图片
Recombinant Human LILRB5/CD85c/LIR-8 Protein (rp148290) - SDS-PAGE 2 μg/lane of Recombinant Human LILRB5/CD85c/LIR-8 Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing the band at 68 kDa.
ZJ25F0723859
危险品化学品经营许可证（带存储）